about
Altered hepatobiliary gene expressions in PFIC1: ATP8B1 gene defect is associated with CFTR downregulationEzrin finds its groove in cholangiocytesA PDZ-Like Motif in the Biliary Transporter ABCB4 Interacts with the Scaffold Protein EBP50 and Regulates ABCB4 Cell Surface Expression.Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferationExpert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor.Role of ErbB/HER family of receptor tyrosine kinases in cholangiocyte biology.Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells.Protein kinase C regulates the phosphorylation and oligomerization of ERM binding phosphoprotein 50.Regulation of electrogenic anion secretion in normal and cystic fibrosis gallbladder mucosa.Characterization of an ankyrin repeat-containing Shank2 isoform (Shank2E) in liver epithelial cells.Mitogen-activated protein kinase-activated protein kinase 2 mediates resistance to hydrogen peroxide-induced oxidative stress in human hepatobiliary cancer cells.Adaptative bile duct proliferative response in experimental bile duct ischemia.Loss of ezrin in human intrahepatic cholangiocarcinoma is associated with ectopic expression of E-cadherin.E-cadherin, guardian of liver physiology.IGF2/IR/IGF1R pathway in tumor cells and myofibroblasts mediates resistance to EGFR inhibition in cholangiocarcinoma.Mechanical induction of the tumorigenic β-catenin pathway by tumour growth pressure.Endothelium-dependent blunted membrane potential responses to ATP-sensitive K+ channel modulators in aortae from rats with cirrhosisUnveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinomaVascular endothelin-1 gene expression and synthesis and effect on renal type I collagen synthesis and nephroangiosclerosis during nitric oxide synthase inhibition in ratsHypoxia-induced changes in the expression of rat hepatobiliary transporter genesInsulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell featuresSignalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance
P50
Q24319097-14421ECD-7A80-4714-A3B7-850692E1DADFQ35528054-DFC13237-72D6-4144-8D10-E4285E129236Q35898848-650A0B57-6098-44EC-829D-91B2EC0F3E66Q37150777-BC442DC2-FE73-4DD2-A21D-A22108592B02Q38812588-B5B6A2D3-AFCD-47EC-BDD4-C3F732296F68Q38968181-279FBED4-47C2-42B7-9C01-789B0A66A0D1Q39007454-AE2AC0AA-94CB-4164-BA30-BD5C4C5B390DQ39076960-6F3D0896-2B48-45B9-BB5B-E097F61C1754Q39137066-F1363FF8-F55B-4062-A6EB-AD21B8203193Q39410914-97F96ECA-CBB1-4309-A5ED-47EE9B43CD2FQ39493807-93C8673B-7700-4404-8C56-B19F7EF83F9BQ40426090-FB1AF6FC-E03D-48B9-AF02-337DB81F323CQ42465669-44348419-15A4-4446-BC0D-91A8B0252478Q43003774-B2C247A3-86B0-42F8-BDCB-E67EC7949ED1Q46701358-F4762852-FCF2-4C4B-BBBC-787C783BE458Q50776604-35C298AF-71D3-4784-B39D-99D58EF34A12Q53201713-FC8AACDD-8317-4E48-BBC2-4D909877CC62Q53227156-57F1417E-D635-448C-BB11-549B305E6494Q54113186-8F6D8A6F-7EAD-45AC-BF0F-F9199EF298D0Q55059234-3F168C64-1246-491E-A78A-47CCFCA509D7Q56925539-D57A5D3A-8E95-4BD3-9C7E-C6BE64E644F4Q60950297-DA73C59B-712F-4F49-B041-374D5F105510Q77367283-2575AA6F-EFD8-4570-AAC9-9EB3FEBD3AC9Q80576322-D022BEB1-A3D6-4141-A504-2ECAC989C8FDQ92230122-9BE5532A-6122-4289-AFA1-653B3354A2FCQ92569012-30994C28-DF3D-4260-B87D-8E30BE29A8A5
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Laura Fouassier
@ast
Laura Fouassier
@en
Laura Fouassier
@es
Laura Fouassier
@nl
type
label
Laura Fouassier
@ast
Laura Fouassier
@en
Laura Fouassier
@es
Laura Fouassier
@nl
prefLabel
Laura Fouassier
@ast
Laura Fouassier
@en
Laura Fouassier
@es
Laura Fouassier
@nl
P106
P31
P496
0000-0001-6377-5610